|
1
|
Kolberg-Liedtke C, Lüftner D, Brucker SY, Budach W, Denkert C, Fasching PA, Haidinger R, Harbeck N, Huober J, Jackisch C, Janni W, Krug D, Kühn T, Loibl S, Müller V, Schneeweiss A, Thomssen C, Untch M, Thill M. Practice-Changing Perspectives regarding Systemic Therapy in Early Breast Cancer: Opinions of German Experts regarding the 17th St. Gallen International Consensus Conference. Breast Care (Basel) 2022; 17:336-345. [PMID: 35957945 PMCID: PMC9247526 DOI: 10.1159/000517501] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2021] [Accepted: 05/31/2021] [Indexed: 09/22/2023] Open
Abstract
The general topic of this year's 17th St. Gallen (SG) International Consensus Conference on the treatment of patients with early breast cancer (SG-BCC) was "Customizing local and systemic therapies for women with early breast cancer." This topic considers that each treatment decision must also consider the cancer-specific situation of the individual patient. This year, the votes of the SG-BCC were again discussed taking into account the multidisciplinary German S3 Guidelines and the recommendations of the Breast Cancer Working Group of the AGO (Arbeitsgemeinschaft Gynäkologische Onkologie; AGO Mamma). As the international panel of the SG-BCC consists of experts from different countries, the votes do represent an international cross-section of opinions. Therefore, it is useful to discuss the voting results with respect to the German evidence-based treatment guidelines. This publication focuses mainly on systemic treatment.
Collapse
Affiliation(s)
- Cornelia Kolberg-Liedtke
- Clinic for Gynecology and Obstetrics, University Hospital of Essen, Essen, Germany
- Palleos Healthcare GmbH, Wiesbaden, Germany
- Phaon Scientific GmbH, Wiesbaden, Germany
| | - Diana Lüftner
- Medical Clinic Specializing in Hematology, Oncology, and Tumor Immunology, Charité Berlin, Virchow Hospital Campus, Berlin, Germany
| | - Sara Y. Brucker
- Department of Women's Health, University Women's Hospital Tübingen, Tübingen, Germany
| | - Wilfried Budach
- Clinic for Radiation Therapy and Radiation Oncology, University Clinic of Düsseldorf, Düsseldorf, Germany
| | - Carsten Denkert
- Pathology Institute, Philipps University of Marburg and University Hospital of Marburg (UKGM), Marburg, Germany
| | - Peter A. Fasching
- Women's Clinic at the University Hospital of Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany
| | | | - Nadia Harbeck
- Breast Center, Department of OB&GYN and CCC Munich LMU, LMU University Hospital, Munich, Germany
| | - Jens Huober
- Breast Center, Cantonal Hospital of St. Gallen, St. Gallen, Switzerland
| | | | | | - David Krug
- Clinic for Radiation Therapy (Radiation Oncology), University Hospital of Schleswig-Holstein, Kiel Campus, Kiel, Germany
| | - Thorsten Kühn
- Clinic for Gynecology and Obstetrics, Esslingen Hospital, Esslingen, Germany
| | - Sibylle Loibl
- German Breast Group, Neu-Isenburg, Germany
- Bethany Center for Hematology and Oncology, Frankfurt, Germany
| | - Volkmar Müller
- Clinic and Outpatient Clinic for Gynecology, University Clinic of Hamburg-Eppendorf (UKE), Hamburg, Germany
| | - Andreas Schneeweiss
- National Center for Tumor Diseases (NCT), University Hospital of Heidelberg (UKHD) and German Cancer Research Center (DKFZ), Heidelberg, Germany
| | - Christoph Thomssen
- University Clinic and Outpatient Clinic for Gynecology, Martin Luther University of Halle-Wittenberg, Halle (Saale), Germany
| | - Michael Untch
- Clinic for Gynecology and Obstetrics, Interdisciplinary Breast Center, HELIOS Hospital of Berlin-Buch, Berlin, Germany
| | - Marc Thill
- Clinic for Gynecology and Gynecological Oncology, Interdisciplinary Breast Center, Agaplesion Markus Hospital, Frankfurt, Germany
| |
Collapse
|